Venbio Partners LLC
CIK:0001776382
Venture Capital
$2B AUM
6 holdings
San Francisco, CA, United States
venBio Partners LLC is a life sciences investment firm focused on biotech, medical devices, and broader life sciences sectors, investing in innovative life science, biotech, and pharma companies.
Investment Strategy
Invests in early and late-stage biotechnology, life sciences, biopharmaceutical, and pharma companies, focusing on novel therapeutics for unmet medical needs.
Top Buys
P
PHVSPHARVARIS N V+$8.1M
L
LYELLYELL IMMUNOPHARMA INC+$4.2M
A
ALMSALUMIS INC-$3.3M
A
ALXOALX ONCOLOGY HLDGS INC-$2.0M
A
ARTVARTIVA BIOTHERAPEUTICS INC-$1.9M
Top Sells
S
SLRNACELYRIN INC-$9.4M
P
PHVSPHARVARIS N V+$8.1M
L
LYELLYELL IMMUNOPHARMA INC+$4.2M
L
LYELLYELL IMMUNOPHARMA INC-$3.8M
A
ALMSALUMIS INC-$3.3M
Top Holdings
P
PHVSPHARVARIS N V+65.8%$75.5M
H
HRMYHARMONY BIOSCIENCES HLDGS IN+13.5%$15.5M
A
ALMSALUMIS INC+12.1%$13.9M
L
LYELLYELL IMMUNOPHARMA INC+3.6%$4.2M
A
ALXOALX ONCOLOGY HLDGS INC+3.5%$4.0M
Equity Positions (6)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
P PHVS | PHARVARIS N V | 65.78% | $75.5M | 4,289,304 | $22.81 | $17.60 | +$8.1M |
H HRMY | HARMONY BIOSCIENCES HLDGS IN | 13.47% | $15.5M | 489,194 | $33.90 | $31.60 | -$777.8K |
A ALMS | ALUMIS INC | 12.08% | $13.9M | 4,619,803 | $8.76 | $3.00 | -$3.3M |
L LYEL | LYELL IMMUNOPHARMA INC | 3.65% | $4.2M | 473,479 | $8.84 | $8.84 | +$4.2M |
A ALXO | ALX ONCOLOGY HLDGS INC | 3.51% | $4.0M | 9,699,925 | $37.74 | $0.42 | -$2.0M |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+98.5%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+1.5%